SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-042469
Filing Date
2023-08-14
Accepted
2023-08-14 16:31:26
Documents
57
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q clsd-20230630.htm   iXBRL 10-Q 1640713
2 EX-31.1 clsd-ex31_1.htm EX-31.1 18166
3 EX-31.2 clsd-ex31_2.htm EX-31.2 17824
4 EX-32.1 clsd-ex32_1.htm EX-32.1 12096
5 GRAPHIC img141477973_0.jpg GRAPHIC 101514
  Complete submission text file 0000950170-23-042469.txt   6235032

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT clsd-20230630_def.xml EX-101.DEF 168690
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT clsd-20230630.xsd EX-101.SCH 51003
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT clsd-20230630_pre.xml EX-101.PRE 285536
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT clsd-20230630_cal.xml EX-101.CAL 31452
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT clsd-20230630_lab.xml EX-101.LAB 394912
51 EXTRACTED XBRL INSTANCE DOCUMENT clsd-20230630_htm.xml XML 950571
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37783 | Film No.: 231171043
SIC: 2834 Pharmaceutical Preparations